These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 14722349)

  • 21. Pulse IV cyclophosphamide in ocular inflammatory disease: efficacy and short-term safety.
    Durrani K; Papaliodis GN; Foster CS
    Ophthalmology; 2004 May; 111(5):960-5. PubMed ID: 15121375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies.
    Huber AM; Feldman BM; Rennebohm RM; Hicks JE; Lindsley CB; Perez MD; Zemel LS; Wallace CA; Ballinger SH; Passo MH; Reed AM; Summers RM; White PH; Katona IM; Miller FW; Lachenbruch PA; Rider LG;
    Arthritis Rheum; 2004 May; 50(5):1595-603. PubMed ID: 15146430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and limitations of pulse cyclophosphamide therapy in polymyositis and dermatomyositis.
    Nagappa M; Taly AB; Sinha S; Gayathri N; Bindu PS; Mahadevan A; Yasha T
    J Clin Neuromuscul Dis; 2013 Jun; 14(4):161-8. PubMed ID: 23703010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination antimalarials in the treatment of cutaneous dermatomyositis: a retrospective study.
    Ang GC; Werth VP
    Arch Dermatol; 2005 Jul; 141(7):855-9. PubMed ID: 16027300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
    Hoyles RK; Ellis RW; Wellsbury J; Lees B; Newlands P; Goh NS; Roberts C; Desai S; Herrick AL; McHugh NJ; Foley NM; Pearson SB; Emery P; Veale DJ; Denton CP; Wells AU; Black CM; du Bois RM
    Arthritis Rheum; 2006 Dec; 54(12):3962-70. PubMed ID: 17133610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis.
    Gladstone DE; Zamkoff KW; Krupp L; Peyster R; Sibony P; Christodoulou C; Locher E; Coyle PK
    Arch Neurol; 2006 Oct; 63(10):1388-93. PubMed ID: 16908728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myelopathies secondary to Sjögren's syndrome: treatment with monthly intravenous cyclophosphamide associated with corticosteroids.
    de Seze J; Delalande S; Fauchais AL; Hachulla E; Stojkovic T; Ferriby D; Hatron PY; Vermersch P
    J Rheumatol; 2006 Apr; 33(4):709-11. PubMed ID: 16583474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
    Mahajan VK; Sharma NL; Sharma RC; Garg G
    Int J Dermatol; 2005 Oct; 44(10):821-7. PubMed ID: 16207182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous cyclophosphamide for lupus nephritis in Thai children.
    Vachvanichsanong P; Dissaneewate P; Winn T
    Scand J Rheumatol; 2004; 33(5):339-42. PubMed ID: 15513684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Two children with skin rash and muscle weakness: juvenile dermatomyositis].
    Boogaard R; Drexhage VR; van Suijlekom-Smit LW
    Ned Tijdschr Geneeskd; 2005 Jan; 149(3):146-50. PubMed ID: 15693592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.
    Mok CC; Ying KY; Ng WL; Lee KW; To CH; Lau CS; Wong RW; Au TC
    Am J Med; 2006 Apr; 119(4):355.e25-33. PubMed ID: 16564783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone mineral apparent density in juvenile dermatomyositis: the role of lean body mass and glucocorticoid use.
    Santiago RA; Silva CA; Caparbo VF; Sallum AM; Pereira RM
    Scand J Rheumatol; 2008; 37(1):40-7. PubMed ID: 18189194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
    Aringer M; Houssiau F; Gordon C; Graninger WB; Voll RE; Rath E; Steiner G; Smolen JS
    Rheumatology (Oxford); 2009 Nov; 48(11):1451-4. PubMed ID: 19748965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose intravenous cyclophosphamide in systemic sclerosis: an open prospective efficacy study in patients with early diffuse disease.
    Valentini G; Paone C; La Montagna G; Chiarolanza I; Menegozzo M; Colutta E; Ruocco L
    Scand J Rheumatol; 2006; 35(1):35-8. PubMed ID: 16467039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy.
    Thorne JE; Woreta FA; Jabs DA; Anhalt GJ
    Ophthalmology; 2008 Dec; 115(12):2146-2152.e1. PubMed ID: 18930554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.
    Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; de Ramon Garrido E; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
    Arthritis Rheum; 2004 Dec; 50(12):3934-40. PubMed ID: 15593207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical features and disease course of patients with juvenile dermatomyositis.
    Gowdie PJ; Allen RC; Kornberg AJ; Akikusa JD
    Int J Rheum Dis; 2013 Oct; 16(5):561-7. PubMed ID: 24164844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease.
    Cassinotti A; Annaloro C; Ardizzone S; Onida F; Della Volpe A; Clerici M; Usardi P; Greco S; Maconi G; Porro GB; Deliliers GL
    Gut; 2008 Feb; 57(2):211-7. PubMed ID: 17895357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose cyclophosphamide results in long-term disease remission with restoration of a normal quality of life in patients with severe refractory chronic inflammatory demyelinating polyneuropathy.
    Gladstone DE; Prestrud AA; Brannagan TH
    J Peripher Nerv Syst; 2005 Mar; 10(1):11-6. PubMed ID: 15703014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: results of an open-label prospective study.
    Gerloni V; Pontikaki I; Gattinara M; Desiati F; Lupi E; Lurati A; Salmaso A; Fantini F
    Arthritis Rheum; 2005 Feb; 52(2):548-53. PubMed ID: 15693004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.